莱美药业：关于获得药品注册证书的公告

Core Viewpoint - Recently, the company received approval from the National Medical Products Administration for two drugs: Nicardipine Tablets (5mg) and Ketorolac Tromethamine Injection (30mg per 1ml) [2] Group 1 - The company announced the receipt of drug registration certificates for Nicardipine Tablets and Ketorolac Tromethamine Injection [2]